FDA Inspection 981667 — UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program

UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program — FEI 2074237

The FDA completed an inspection of UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program on Jul 7, 2016 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 7, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.